Patents Assigned to GW Pharmaceuticals Limited
  • CANNABINOIDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES OR DISORDERS
    Publication number: 20140228438
    Abstract: The present invention relates to cannabinoids for use in the prevention or treatment of neurodegenerative diseases or disorders. Preferably the cannabinoids are cannabichromene (CBC) cannabidivarin (CBDV) and/or cannabidivarin acid (CBDVA). More preferably the neurodegenerative disease or disorder to be prevented or treated is Alzheimer's disease.
    Type: Application
    Filed: June 29, 2012
    Publication date: August 14, 2014
    Applicant: GW Pharmaceuticals Limited
    Inventors: Teresa Iuvone, Vincenzo Di Marzo, Geoffrey Guy, Stephen Wright, Colin Stott
  • Pharmaceutical formulations
    Publication number: 20020136752
    Abstract: The invention relates to pharmaceutical formulations for use in the administration of medicaments, in particular lipophilic medicaments, via mucosal surfaces.
    Type: Application
    Filed: April 5, 2001
    Publication date: September 26, 2002
    Applicant: GW Pharmaceuticals Limited
    Inventors: Brian A. Whittle, Geoffrey W. Guy